Clinical Trial

Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder

Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial investigates the comparative effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy and selective serotonin reuptake inhibitors (SSRIs) in fostering post-traumatic growth among patients diagnosed with post-traumatic stress disorder (PTSD). Participants will be randomized to receive either EMDR therapy or standard SSRI pharmacotherapy. The primary objective is to evaluate the extent of psychological growth and recovery achieved through each intervention, aiming to guide future therapeutic strategies for PTSD.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-26; most recent amendment 2026-05-03.
Status change: Active, Not Recruiting → Completed 2026-05-03
Status change: Recruiting → Active, Not Recruiting 2025-07-04
Status change: Not Yet Recruiting → Recruiting 2025-05-05
Trial Details
NCT Number NCT06957210
Lead Sponsor Asad Ullah Jan
Conditions PTSD - Post Traumatic Stress Disorder
Enrollment 130 participants
Start Date 2025-05-06
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-07